Alteration of Aβ metabolism-related molecules in predementia induced by AlCl3 and d-galactose (original) (raw)
References
Benson AD, Slavin MJ, Tran TT, Petrella JR, Doraiswamy PM (2005) Screening for early Alzheimer’s disease: is there still a role for the mini-mental state examination? Prim Care Companion J Clin Psychiat 7:62–69 Article Google Scholar
Deane R, Wu Z, Zlokovic BV (2004) RAGE (yin) versus LRP (yang) balance regulates alzheimer amyloid beta-peptide clearance through transport across the blood-brain barrier. Stroke 35:2628–2631. doi:10.1161/01.STR.0000143452.85382.d1 ArticleCASPubMed Google Scholar
Donahue JE, Flaherty SL, Johanson CE, Duncan JA 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG (2006) RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease. Acta Neuropathol 112:405–415. doi:10.1007/s00401-006-0115-3 ArticleCASPubMed Google Scholar
Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100:4162–4167. doi:10.1073/pnas.0230450100 ArticleCASPubMed Google Scholar
Farris W, Mansourian S, Leissring MA, Eckman EA, Bertram L, Eckman CB, Tanzi RE, Selkoe DJ (2004) Partial loss-of-function mutations in insulin-degrading enzyme that induce diabetes also impair degradation of amyloid beta-protein. Am J Pathol 164:1425–1434 CASPubMed Google Scholar
Fox NC, Black RS, Gilman S, Rossor MN, Griffith SG, Jenkins L, Koller M (2005) Effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 64:1563–1572. doi:10.1212/01.WNL.0000159743.08996.99 ArticleCASPubMed Google Scholar
Fritzsche KH, von Wangenheim A, Abdala DD, Meinzer HP (2008) A computational method for the estimation of atrophic changes in Alzheimer's disease and mild cognitive impairment. Comput Med Imaging Graph 32:294–303. doi:10.1016/j.compmedimag.2007.12.006 ArticlePubMed Google Scholar
Gustaw KA, Garrett MR, Lee HG, Castellani RJ, Zagorski MG, Prakasam A, Siedlak SL, Zhu X, Perry G, Petersen RB, Friedland RP, Smith MA (2008) Antigen-antibody dissociation in Alzheimer disease: a novel approach to diagnosis. J Neurochem 106:1350–1356. doi:10.1111/j.1471-4159.2008.05477.x ArticleCASPubMed Google Scholar
Hama E, Shirotani K, Masumoto H, Sekine-Aizawa Y, Aizawa H, Saido TC (2001) Clearance of extracellular and cell-associated amyloid beta peptide through viral expression of neprilysin in primary neurons. J Biochem 130:721–726 CASPubMed Google Scholar
Hampel H, Burger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K (2008) Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimers Dement 4:38–48. doi:10.1016/j.jalz.2007.08.006 ArticleCASPubMed Google Scholar
Harada H, Tamaoka A, Ishii K, Shoji S, Kametaka S, Kametani F, Saito Y, Murayama S (2006) Beta-site APP cleaving enzyme 1 (BACE1) is increased in remaining neurons in Alzheimer's disease brains. Neurosci Res 54:24–29. doi:10.1016/j.neures.2005.10.001 ArticleCASPubMed Google Scholar
Iwata N, Takaki Y, Fukami S, Tsubuki S, Saido TC (2002) Region-specific reduction of a beta-degrading endopeptidase, neprilysin, in mouse hippocampus upon aging. J Neurosci Res 70:493–500. doi:10.1002/jnr.10390 ArticleCASPubMed Google Scholar
Kim M, Hersh LB, Leissring MA, Ingelsson M, Matsui T, Farris W, Lu A, Hyman BT, Selkoe DJ, Bertram L, Tanzi RE (2007) Decreased catalytic activity of the insulin-degrading enzyme in chromosome 10-linked Alzheimer disease families. J Biol Chem 282:7825–7832. doi:10.1074/jbc.M609168200 ArticleCASPubMed Google Scholar
Leal MC, Dorfman VB, Gamba AF, Frangione B, Wisniewski T, Castano EM, Sigurdsson EM, Morelli L (2006) Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology. J Neuropathol Exp Neurol 65:976–987. doi:10.1097/01.jnen.0000235853.70092.ba ArticleCASPubMed Google Scholar
Leclerc E, Fritz G, Weibel M, Heizmann CW, Galichet A (2007) S100B and S100A6 differentially modulate cell survival by interacting with distinct RAGE (receptor for advanced glycation end products) immunoglobulin domains. J Biol Chem 282:31317–31331. doi:10.1074/jbc.M703951200 ArticleCASPubMed Google Scholar
Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, Beach T, Sue L, Sabbagh M, Cai H, Wong P, Price D, Shen Y (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients. Proc Natl Acad Sci USA 101:3632–3637. doi:10.1073/pnas.0205689101 ArticleCASPubMed Google Scholar
Luo Y, Niu F, Wang L, Cao W, Zhang X, Lv Z, Zhang B, Xu Y (2008) Altered expression of Abeta metabolism-associated molecules from d-galactose/AlCl(3) induced mouse brain. Mech Ageing Dev . doi:10.1016/j.mad.2008.12.005 PubMed Google Scholar
Luques L, Shoham S, Weinstock M (2007) Chronic brain cytochrome oxidase inhibition selectively alters hippocampal cholinergic innervation and impairs memory: prevention by ladostigil. Exp Neurol 206:209–219. doi:10.1016/j.expneurol.2007.04.007 ArticleCASPubMed Google Scholar
McConlogue L, Buttini M, Anderson JP, Brigham EF, Chen KS, Freedman SB, Games D, Johnson-Wood K, Lee M, Zeller M, Liu W, Motter R, Sinha S (2007) Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP Transgenic Mice. J Biol Chem 282:26326–26334. doi:10.1074/jbc.M611687200 ArticleCASPubMed Google Scholar
Miller BC, Eckman EA, Sambamurti K, Dobbs N, Chow KM, Eckman CB, Hersh LB, Thiele DL (2003) Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci USA 100:6221–6226. doi:10.1073/pnas.1031520100 ArticleCASPubMed Google Scholar
Miller MC, Tavares R, Johanson CE, Hovanesian V, Donahue JE, Gonzalez L, Silverberg GD, Stopa EG (2008) Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease. Brain Res 1230:273–280. doi:10.1016/j.brainres.2008.06.124 ArticleCASPubMed Google Scholar
Mohajeri MH, Wollmer MA, Nitsch RM (2002) Abeta 42-induced increase in neprilysin is associated with prevention of amyloid plaque formation in vivo. J Biol Chem 277:35460–35465. doi:10.1074/jbc.M202899200 ArticleCASPubMed Google Scholar
Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699. doi:10.1111/j.1532-5415.2005.53221.x ArticlePubMed Google Scholar
Ohno M, Sametsky EA, Younkin LH, Oakley H, Younkin SG, Citron M, Vassar R, Disterhoft JF (2004) BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease. Neuron 41:27–33. doi:10.1016/S0896-6273(03)00810-9 ArticleCASPubMed Google Scholar
Ohno M, Cole SL, Yasvoina M, Zhao J, Citron M, Berry R, Disterhoft JF, Vassar R (2007) BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiol Dis 26:134–145. doi:10.1016/j.nbd.2006.12.008 ArticleCASPubMed Google Scholar
Stern D, Yan SD, Yan SF, Schmidt AM (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv Drug Deliv Rev 54:1615–1625. doi:10.1016/S0169-409X(02)00160-6 ArticleCASPubMed Google Scholar
Tamagno E, Bardini P, Obbili A, Vitali A, Borghi R, Zaccheo D, Pronzato MA, Danni O, Smith MA, Perry G, Tabaton M (2002) Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol Dis 10:279–288. doi:10.1006/nbdi.2002.0515 ArticleCASPubMed Google Scholar
Tamagno E, Parola M, Bardini P, Piccini A, Borghi R, Guglielmotto M, Santoro G, Davit A, Danni O, Smith MA, Perry G, Tabaton M (2005) β-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J Neurochem 92:628–636. doi:10.1111/j.1471-4159.2004.02895 ArticleCASPubMed Google Scholar
Tanzi RE, Moir RD, Wagner SL (2004) Clearance of Alzheimer’s Abeta peptide: the many roads to perdition. Neuron 43:605–608 CASPubMed Google Scholar
Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B (2007) Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol 14:e1–e26. doi:10.1111/j.1468-1331.2006.01605.x ArticleCASPubMed Google Scholar
Wiltfang J, Lewczuk P, Riederer P, Grunblatt E, Hock C, Scheltens P, Hampel H, Vanderstichele H, Iqbal K, Galasko D, Lannfelt L, Otto M, Esselmann H, Henkel AW, Kornhuber J, Blennow K (2005) Consensus paper of the WFSBP Task Force on Biological Markers of Dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry 6:69–84. doi:10.1080/15622970510029786 ArticleCASPubMed Google Scholar
Xu Y, Zhang W, Klaus J, Young J, Koerner I, Sheldahl LC, Hurn PD, Martinez-Murillo F, Alkayed NJ (2006) Role of cocaine- and amphetamine-regulated transcript in estradiol-mediated neuroprotection. Proc Natl Acad Sci USA 103:14489–14494. doi:10.1073/pnas.0602932103 ArticleCASPubMed Google Scholar
Yasojima K, Akiyama H, McGeer EG, McGeer PL (2001) Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of beta-amyloid peptide. Neurosci Lett 297:97–100. doi:10.1016/S0304-3940(00)01675-X ArticleCASPubMed Google Scholar
Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis. J Neurosci 27:3639–3649. doi:10.1523/JNEUROSCI.4396-06.2007 ArticleCASPubMed Google Scholar